GEN Exclusives

More »

GEN News Highlights

More »
Feb 13, 2007

ChemDiv to Provide Merck With Discovery Chemistry in Multiyear Agreement

  • Merck extended it’s partnership with ChemDiv until 2009 to provide discovery libraries of lead-like small molecules. The new agreement expands the collaboration that has been going on for the last three years, and roughly doubles the FTE effort at ChemDiv's Chemical Diversity Research Institute in Moscow.

    "This new agreement reflects the success of our previous relationship and our high esteem for the quality of ChemDiv's discovery and synthesis capabilities," says Peter Raddatz, vp of medicinal chemistry at Merck. "ChemDiv will continue to complement our in-house activities to add further diversity and novelty to Merck's discovery projects."

    A steering committee with representatives from Merck and ChemDiv will determine projects to be produced by ChemDiv for early-stage discovery at Merck. Promising hits will then be further optimized and placed into Merck's discovery pipeline.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »